Correlation between increased platelet ADP aggregability and silent brain infarcts

Brain and Nerve

Volumn 64, Issue 2, 2012, Pages 185-189

  Ono, Kenichiro ^a   Arimoto, Hirohiko ^a   Shirotani, Toshiki ^a  

^a Japan Self Defense Forces Central Hospital   (Japan)

Author keywords

Hyperaggregability; Lacunar stroke; Platelet aggregation; Risk factors; Silent brain infarcts

Indexed keywords

ADENOSINE DIPHOSPHATE;

ADULT; ARTICLE; BLOOD SAMPLING; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEADACHE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTRACRANIAL VESSEL STENOSIS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK FACTOR; SILENT BRAIN INFARCT; SMOKING; STENOSIS; THROMBOCYTE AGGREGATION; VERTIGO;

CEREBRAL INFARCTION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLATELET AGGREGATION; RISK FACTORS;

EID: 84857292336     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Couch JR, Hassanein RS: Platelet aggregation, stroke, and transient ischemic attack in middle-aged and elderly patients. Neurology 26: 888-895, 1976
2. Uchiyama S, Yamazaki M, Maruyama S, Handa M, Ikeda Y, et al: Shear-induced platelet aggregation in cerebral ischemia. Stroke 25: 1547-1551, 1994 (Pubitemid 24233956)
3. Nakajima S, Noguchi T, Taka T, Ueda T, Kaizu K, et al: A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke. Platelets 11: 459-466, 2000 (Pubitemid 32147032)
4. Shinohara Y, Gotoh F, Tohgi H, Hirai S, Terashi A, et al: Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study. Cerebrovasc Dis 26: 63-70, 2008 (Pubitemid 351931422)
5. Vermeer SE, Longstreth Jr WT, Koudstaal PJ: Silent brain infarcts: a systematic review. Lancet Neurol 6: 611-619, 2007 (Pubitemid 46921055)
6. Bokura H, Kobayashi S, Yamaguchi S, Iijima K, Nagai A, et al: Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J Stroke Cerebrovasc Dis 15: 57-63, 2006 (Pubitemid 43324967)
7. Das RR, Seshadri S, Beiser AS, Kelly-Hayes M, Au R, et al: Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke 39: 2929-2935, 2008
8. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S: Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 28: 1932-1939, 1997 (Pubitemid 27458998)
9. Caplan LR: Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology 39: 1246-1250, 1989
10. Johnson M, Ramey E, Ramwell PW: Sex and age differences in human platelet aggregation. Nature 253: 355-357, 1975
11. Ruggeri ZM: Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 1: 1335-1342, 2003
12. DiChiara J, Bliden KP, Tantry US, Hamed MS, Antonino MJ, et al: The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. Diabetes 56: 3014-3019, 2007 (Pubitemid 350223637)
13. Mansouri A, Perry CA: Alteration of platelet aggregation by cigarette smoke and carbon monoxide. Thromb Haemost 48: 286-288, 1982 (Pubitemid 13209595)
14. Fujita S, Kawaguchi T, Uehara T, Fukushima K: Progress of leukoaraiosis is inhibited by correction of platelet hyper-aggregability. Int Psychogeriatr 17: 689-698, 2005 (Pubitemid 41758771)